Md Yusof, MY, Vital, EM and Emery, P (2014) Biologics in systemic lupus erythematosus: current options and future perspectives. British Journal of Hospital Medicine, 75 (8). 440 - 447. ISSN 1750-8460
Abstract
Data from clinical trials highlighted the potential and pitfalls of the use of biologics to treat systemic lupus erythematosus. With improved understanding of immunopathogenesis and lessons learned from controlled trials, there is a growing optimism for personalized treatment from an increasing range of targeted therapies.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 30 Jul 2015 10:26 |
Last Modified: | 31 Jul 2015 07:37 |
Published Version: | http://dx.doi.org/10.12968/hmed.2014.75.8.440 |
Status: | Published |
Publisher: | Mark Allen Healthcare |
Identification Number: | 10.12968/hmed.2014.75.8.440 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:85070 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online